Aws Cloud Lyell Immunopharma [shutterstock: 639884194, Matej Kastelic]
[shutterstock: 639884194, Matej Kastelic]
Cloud Press Release

Lyell Immunopharma Goes All-In On AWS As Its Cloud Provider

Lyell Immunopharma, a cellular therapy company, seeks to accelerate research of cell-based immunotherapies for cancer and other diseases by relying upon AWS’s portfolio of cloud services.

Amazon Web Services (AWS) announced that Lyell Immunopharma is going all-in on AWS – running its cloud infrastructure on AWS – and has selected AWS as its standard for machine learning (ML) workloads.

Lyell leverages AWS’s infrastructure to run its secure data and analytics platform as well as support its high-performance computing workloads to accelerate the research of new cell therapies as it searches for cures for cancer.

How Lyell leverages AWS

AWS’s breadth and depth of services is helping Lyell to uncover insights in scientific data on how the immune system can fight cancer, as well as speed up its research. One of Lyell’s approaches to developing immunotherapies is using high performance computing (HPC) clusters to help scientists design new protein structures to engineer immune cells that are more capable of fighting cancer. Using AWS’s secure and elastic compute capacity, Lyell is able to design and test potential new cell therapy constructs at a faster rate, going from conducting a single simulation in four weeks to completing 30 simulations in 10 hours.

By building a data lake on Amazon Simple Storage Service (Amazon S3), and leveraging AWS analytics services such as Amazon Athena and Amazon EMR, Lyell can now analyze petabytes of research, clinical, and manufacturing data to gain insights into immune cell functionality faster than ever before.

Lyell is also using Amazon SageMaker to enable scientists to build, train, and deploy ML models. These models enable automated image analysis and optimization of protein structures, which will facilitate Lyell’s mission to cure cancer.


About the author

E-3 Magazine

Articles published through E-3 Magazine International. This includes press releases by our partners as well as articles and reports from the E-3 team of journalists.

Add Comment

Click here to post a comment

Sign up for e3zine´s biweekly newsbites

Please do not use administrative mail adresses like "noreply@..", "admin@.." or similar as these may get blocked for security reasons.

We use rapidmail for dispatching our newsletter. By signing up, you agree that the data you have entered will be transmitted to rapidmail. Please take note of their terms and conditions and privacy policy.termsandconditions.

Our Authors